According to the latest report by The Insight Partners, this segment — encompassing technologies such as culture platforms and drug screening tools — is projected to witness sustained growth through 2034, underpinned by rising research investments, increasing demand for predictive cellular assays, and evolution of high‑throughput systems. The 3D Cell Culture Equipment & Tool...